# Pharmacodynamic Open-Label Trial With VXA-A1.1 Oral H1 Vaccine in Healthy Adults

> **NCT03121339** · PHASE1 · COMPLETED · sponsor: **Vaxart** · enrollment: 8 (actual)

## Conditions studied

- Seasonal Influenza Preventative Vaccine Pharmacodynamics

## Interventions

- **BIOLOGICAL:** VXA-A1.1 H1 Tablet Vaccine (small)
- **BIOLOGICAL:** VXA-A1.1 H1 Tablet Vaccine (large)

## Key facts

- **NCT ID:** NCT03121339
- **Lead sponsor:** Vaxart
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-31
- **Primary completion:** 2017-05-05
- **Final completion:** 2018-04-03
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2018-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03121339

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03121339, "Pharmacodynamic Open-Label Trial With VXA-A1.1 Oral H1 Vaccine in Healthy Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03121339. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*